These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 31806407)
1. Circulating microRNAs (miR-21, miR-223, miR-885-5p) along the clinical spectrum of HCV-related chronic liver disease in Egyptian patients. Nasser MZ; Zayed NA; Mohamed AM; Attia D; Esmat G; Khairy A Arab J Gastroenterol; 2019 Dec; 20(4):198-204. PubMed ID: 31806407 [TBL] [Abstract][Full Text] [Related]
2. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients. Shaheen NMH; Zayed N; Riad NM; Tamim HH; Shahin RMH; Labib DA; ELsheikh SM; Moneim RA; Yosry A; Khalifa RH Virus Res; 2018 Aug; 255():77-84. PubMed ID: 30003924 [TBL] [Abstract][Full Text] [Related]
3. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection. El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725 [TBL] [Abstract][Full Text] [Related]
4. Serum microRNA let-7a-1/let-7d/let-7f and miRNA 143/145 Gene Expression Profiles as Potential Biomarkers in HCV Induced Hepatocellular Carcinoma. Aly DM; Gohar NA; Abd El-Hady AA; Khairy M; Abdullatif MM Asian Pac J Cancer Prev; 2020 Feb; 21(2):555-562. PubMed ID: 32102538 [TBL] [Abstract][Full Text] [Related]
5. Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patients. Elemeery MN; Badr AN; Mohamed MA; Ghareeb DA World J Gastroenterol; 2017 Jun; 23(21):3864-3875. PubMed ID: 28638226 [TBL] [Abstract][Full Text] [Related]
6. Serum miR-483-5p and miR-133a as Biomarkers for Diagnosis of Hepatocellular Carcinoma Post-Hepatitis C Infection in Egyptian Patients. Hassan AS; Elgendy NA; Tawfik NA; Elnasser AM Egypt J Immunol; 2019 Jul; 26(2):31-40. PubMed ID: 31926493 [TBL] [Abstract][Full Text] [Related]
7. Serum Beta-2 Microglobulin: a Possible Marker for Disease Progression in Egyptian Patients with Chronic HCV Related Liver Diseases. Ouda SM; Khairy AM; Sorour AE; Mikhail MN Asian Pac J Cancer Prev; 2015; 16(17):7825-9. PubMed ID: 26625805 [TBL] [Abstract][Full Text] [Related]
8. Circulating microRNAs as predictive biomarkers for liver disease progression of chronic hepatitis C (genotype-4) Egyptian patients. El-Hefny M; Fouad S; Hussein T; Abdel-Hameed R; Effat H; Mohamed H; Abdel Wahab AH J Med Virol; 2019 Jan; 91(1):93-101. PubMed ID: 30133717 [TBL] [Abstract][Full Text] [Related]
9. Serum microRNA expression profiling identifies serum biomarkers for HCV-related hepatocellular carcinoma. Li J; Jin B; Wang T; Li W; Wang Z; Zhang H; Song Y; Li N Cancer Biomark; 2019; 26(4):501-512. PubMed ID: 31658041 [TBL] [Abstract][Full Text] [Related]
10. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection. Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989 [TBL] [Abstract][Full Text] [Related]
11. Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients. Zhang S; Ouyang X; Jiang X; Gu D; Lin Y; Kong SK; Xie W Int J Med Sci; 2015; 12(7):590-8. PubMed ID: 26283876 [TBL] [Abstract][Full Text] [Related]
12. miRNA-221 and miRNA-222 are promising biomarkers for progression of liver fibrosis in HCV Egyptian patients. Abdel-Al A; El-Ahwany E; Zoheiry M; Hassan M; Ouf A; Abu-Taleb H; Abdel Rahim A; El-Talkawy MD; Zada S Virus Res; 2018 Jul; 253():135-139. PubMed ID: 29932949 [TBL] [Abstract][Full Text] [Related]
13. Expression analysis of liver-specific circulating microRNAs in HCV-induced hepatocellular Carcinoma in Egyptian patients. Mourad L; El-Ahwany E; Zoheiry M; Abu-Taleb H; Hassan M; Ouf A; Rahim AA; Hassanien M; Zada S Cancer Biol Ther; 2018 May; 19(5):400-406. PubMed ID: 29333940 [TBL] [Abstract][Full Text] [Related]
14. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients. Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA PLoS One; 2015; 10(9):e0137706. PubMed ID: 26352740 [TBL] [Abstract][Full Text] [Related]
15. Serum microRNAs; miR-30c-5p, miR-223-3p, miR-302c-3p and miR-17-5p could be used as novel non-invasive biomarkers for HCV-positive cirrhosis and hepatocellular carcinoma. Oksuz Z; Serin MS; Kaplan E; Dogen A; Tezcan S; Aslan G; Emekdas G; Sezgin O; Altintas E; Tiftik EN Mol Biol Rep; 2015 Mar; 42(3):713-20. PubMed ID: 25391771 [TBL] [Abstract][Full Text] [Related]
16. Serum miRNA Panel in Egyptian Patients with Chronic Hepatitis C Related Hepatocellular Carcinoma. Khairy A; Hamza I; Shaker O; Yosry A Asian Pac J Cancer Prev; 2016; 17(5):2699-703. PubMed ID: 27268654 [TBL] [Abstract][Full Text] [Related]
17. Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients. Fteah AM; Ahmed AI; Mosaad NA; Hassan MM; Mahmoud SH Asian Pac J Cancer Prev; 2019 Nov; 20(11):3479-3485. PubMed ID: 31759375 [TBL] [Abstract][Full Text] [Related]
18. Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma. Jin Y; Wong YS; Goh BKP; Chan CY; Cheow PC; Chow PKH; Lim TKH; Goh GBB; Krishnamoorthy TL; Kumar R; Ng TP; Chong SS; Tan HH; Chung AYF; Ooi LLPJ; Chang JPE; Tan CK; Lee CGL Sci Rep; 2019 Jul; 9(1):10464. PubMed ID: 31320713 [TBL] [Abstract][Full Text] [Related]
19. Plasma miR-15b-5p, miR-338-5p, and miR-764 as Biomarkers for Hepatocellular Carcinoma. Chen Y; Chen J; Liu Y; Li S; Huang P Med Sci Monit; 2015 Jun; 21():1864-71. PubMed ID: 26119771 [TBL] [Abstract][Full Text] [Related]
20. Serum MicroRNA-122 and MicroRNA-155: Markers of Disease Progression in Hepatitis C viral infection. Sheneef A; Gouda AM; Mohammad AN; Yousef LM; Noureldin AK Egypt J Immunol; 2017 Jun; 24(2):33-46. PubMed ID: 29528577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]